October 2, 2008 – 1:36 pm
The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of Annals of Internal Medicine. Results did not corroborate findings of an earlier multicenter study that showed stool DNA testing was more accurate than fecal blood testing [...]
October 1, 2008 – 9:12 pm
A study led by Mayo Clinic has found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe Crohn’s disease than azathioprine alone. The findings were presented Oct. 6 at the 2008 American College of Gastroenterology (ACG) Annual Meeting.
Crohn’s disease is an inflammatory [...]
September 17, 2008 – 6:02 pm
A study conducted by researchers at Mayo Clinic shows that obese patients with specific genetic make-up had enhanced response to the weight loss drug sibutramine, while others who lack these genetic factors lost little or no weight.
The findings are published in the October issue of Gastroenterology.
In this randomized, double-blind, placebo-controlled study, Mayo researchers measured the [...]
